Compare CCEL & NBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CCEL | NBY |
|---|---|---|
| Founded | 1989 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Managed Health Care | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 27.8M | 31.6M |
| IPO Year | 2022 | 2007 |
| Metric | CCEL | NBY |
|---|---|---|
| Price | $3.62 | $1.95 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 7.3K | ★ 608.2K |
| Earning Date | 04-14-2026 | 05-14-2026 |
| Dividend Yield | ★ 4.26% | N/A |
| EPS Growth | N/A | ★ 35.42 |
| EPS | 0.01 | ★ 0.76 |
| Revenue | ★ $25,384,279.00 | $370,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $339.00 | ★ $2.57 |
| Revenue Growth | ★ 9.76 | N/A |
| 52 Week Low | $2.72 | $0.43 |
| 52 Week High | $5.52 | $19.95 |
| Indicator | CCEL | NBY |
|---|---|---|
| Relative Strength Index (RSI) | 44.38 | 57.82 |
| Support Level | $3.18 | $1.01 |
| Resistance Level | $4.04 | $2.52 |
| Average True Range (ATR) | 0.20 | 0.26 |
| MACD | -0.02 | 0.11 |
| Stochastic Oscillator | 22.39 | 96.45 |
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.